Statistics
Publications
1
Citations
56
H-Index
1
Active since
2022
Affiliations
National Cancer Institute(Current)
Shruti Chandra is an author at National Cancer Institute specializing in immunotherapy, malignant neoplasms, and melanoma classification.
Publications per year
2022–2022
1
1
LBA6 Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801)
S. Patel, Megan Othus, Víctor M. Prieto et al. · Annals of Oncology · 2022 · 56 citations · Full text
Medicine, Oncology, Immunotherapy +15
1–1 of 1